NOTICE 27 AUGUST 2024 SHARES The shares of Faron Pharmaceuticals Ltd. were given observation status on 19 February 2024 on the grounds of the Nasdaq First North Growth Market - Rulebook (rule 6.3.1 article (g)). Nasdaq First North Growth Market Rulebook rule 6.3.1 article (g): "there is a material adverse uncertainty in respect of the Issuer's financial position". The grounds on which the shares were given observation status no longer exist. Nasdaq Helsinki Oy, Surveillance, survo@nasdaq.com, +358 9 6166 7260
© 2024 GlobeNewswire
